Keratin 4 upregulation by retinoic acid in vivo: A sensitive marker for retinoid bioactivity in human epidermis

Journal of Investigative Dermatology

Volumn 114, Issue 3, 2000, Pages 487-493

  Virtanen, Marie ^a   Törmä, Hans ^a   Vahlquist, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Housekeeping genes; Immunohistochemistry; Quantitative real time polymerase chain reaction; Tazarotene

Indexed keywords

BETA ACTIN; CALCIPOTRIOL; KERATIN; KERATIN 4; RETINOIC ACID; TAZAROTENE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034088160     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00901.x     Document Type: Article

References (35)

1. Bloor B, Su L, Shirlow P, Morgan P: Gene expression of differentiation-specific keratins (4/13 and 1/10) in normal human buccal mucosa. Lab Invest 78:787-795, 1998
2. Chambon P: A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954, 1996
3. Chandraratna RAS: Tazarotene - First of a new generation of receptor-selective retinoids. Br J Dermatol 135 (Suppl 49):18-25, 1996
4. Didierjean L, Carraux P, Grand D, Sass JO, Nau H, Saurat J-H: Topical retinaldehyde increases skin content of retinoic acid and exerts biologic activity in the mouse skin. J Invest Dermatol 107:714-719, 1996
5. Eichner R, Kahn M, Capetola RJ, Gendimenico GJ, Mezick JA: Effects of topical retinoids on cytoskeletal proteins - implications for retinoid effects on epidermal differentiation. J Invest Dermatol 98:154-161, 1992
6. Elder JT, Cromie M, Griffiths CEM, Chambon P, Voorhees JJ: Stimulus-selective induction of CRABP II mRNA. A marker for retinoic acid action in human skin. J Invest Dermatol 100:356-359, 1993
7. Fisher GJ, Reddy AP, Datta SC, Kang S, Yi JY, Chambon P, Voorhees JJ: All-trans retinoic acid induces cellular retinol-binding protein in human skin in vivo. J Invest Dermatol 105:80-86, 1995
8. Fuchs E: Keratins and the skin. Annu Rev Cell Dev Biol 11:123-153, 1995
9. Fuchs E, Cleveland DW: A structural scaffolding of intermediate filaments in health and disease. Science 279:514-519, 1998
10. Griffiths C, Finkel L, Transfaglia M, Hamilton T, Voorhees J: An in vivo experimental model for effects of topical retinoic acid in human skin. Br J Dermatol 129:389-394, 1993
11. Griffiths CEM, Dabelsteen E, Voorhees JJ: Topical retinoic acid changes the epidermal cell surface glycosylation pattern towards that of a mucosal epithelium. Br J Dermatol 134:431-436, 1996
12. Heid C, Stevens J, Livak K, Williams P: Real time quantitative PCR. Genome Res 6:986-994, 1996
13. Leigh IM, Purkis PE, Whitehead P, Lane EB: Monospecific monoclonal antibodies to keratin 1 carboxy terminal (synthetic peptide) and to keratin 10 as a marker of epidermal differentiation. Br J Dermatol 129:110-119, 1993
14. Moll R, Moll I, Franke W: Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 276:349-363, 1984
15. van Muijen GN, Riuter DJ, Franke WW, Achtstatter T, Haasnoot WH, Ponec M, Warnaar SO: Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res 162:97-113, 1986
16. Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RAS: Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol 106:269-274, 1996
17. Nagpal S, Patel S, Jacobe H, et al: Tazarotene-induced gene 2 (TIG 2), a novel retinoid-responsive gene in skin. J Invest Dermatol 109:91-95, 1997
18. Navarro JM, Casatorres J, Jorcano JL: Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 270:21362-21367, 1995
19. Perkins W, Campbell I, Leigh IM, MacKie RM: Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. J Cutan Pathol 19:476-482, 1992
20. Reichelt J, Bauer C, Porter RM, Lane EB, Herzog V, Magin TM: Out of balance: consequences of a partial keratin 10 knockout. J Cell Sci 110:2175-2186, 1997
21. Romano V, Bosco P, Rocchi M, Costa G, Leube RE, Franke WW, Romeo G: Chromosomal assignment of human type I and type II cytokeratins genes to different chromosomes. Cytogenet Cell Genet 48:148-151, 1988
22. Rosenthal DS, Griffiths CEM, Yuspa SH, Roop DR, Voorhees JJ: Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratin 6 and keratin 13 but not keratin 1, keratin 10, and keratin 14. J Invest Dermatol 98:343-350, 1992
23. Saurat JH, Didierjean L, Masgrau E, et al: Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol 103:770-774, 1994
24. Schweizer J, Fürstenberger G, Winter H: Selective suppression of two postnatally acquired 70 kD and 65 kD keratin proteins during continuous treatment of adult mouse tail epidermis with vitamin A. J Invest Dermatol 89:125-131, 1987
25. Siegenthaler G: Gel electrophoresis of cellular retinoic acid-binding protein, cellular retinol-binding protein and serum retinol-binding protein. Methods Enzymol 189:299-307, 1990
26. Siegenthaler G, Samson J, Bernard J-P, Fiore-Donno G, Saurat J-H: Retinoid-binding proteins in human oral mucosa. J Oral Pathol 17:106-112, 1988
27. Steijlen PM, van Happle R, Muijen GN, van de Kerkhof PC: Topical treatment with 13-cis retinoic acid improves Darier's disease and induces the expression of a unique keratin pattern. Dermatologica 182:178-183, 1991
28. Steijlen PM, Reifenschweiler DO, van Ramaekers FC, et al: Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid - A clinical and immunohistochemical study. Arch Dermatol Res 285:221-226, 1993
29. Tomic M, Jiang C-K, Epstein HS, Freedberg IM, Samuels HH, Blumenberg M: Nuclear receptors for retinoic acid and thyroid hormone regulate transcription of keratin genes. Cell Regul 1:965-973, 1990
30. Törmä H, Karlsson T, Michaëlsson G, Rollman O, Vahlquist A: Decreased mRNA levels of retinoic acid receptor α, retinoid X receptor α and thyroid receptor α in lesional psoriatic skin. Acta Derm Venereol 80:4-9, 2000.
31. Vahlquist A. Role of retinoids in normal and diseased skin. In: Blomhoff R (ed.). Vitamin A in Health and Disease. New York: Marcel Dekker, Inc., 1994: pp 365-424
32. Vahlquist A, Lee JB, Michaëlsson G, Rollman O: Vitamin A in human skin: II. Concentrations of carotene, retinol and dehydroretinol in various components of normal skin. J Invest Dermatol 79:94-97, 1982
33. Wang S-Y, LaRosa GJ, Gudas LJ: Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol 107:75-86, 1985
34. Wanner R, Zhang J, Dorbic T, Mischke D, Henz BM, Wittig B, Rosenbach T: The promoter of the HaCaT keratinocyte differentiation-related gene keratin 4 contains a functional AP-2 binding site. Arch Dermatol Res 289:705-708, 1997
35. Wu Y-Y, Rees J: Variations in epidermal housekeeping gene expression in different pathological states. Acta Derm Venereol 80:2-3, 2000